메뉴 건너뛰기
Nature Clinical Practice Oncology
Volumn 2, Issue 11, 2005, Pages 536-537
What is the value of screening for prostate cancer in the US?
Author keywords

[No Author keywords available]
Indexed keywords

FINASTERIDE; PLACEBO; PROSTATE SPECIFIC ANTIGEN;
EID: 28444491466     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0348     Document Type: Review
Times cited : (10)
References (10)
  • 1
    • 2442715038 scopus 로고    scopus 로고
    • Prevalence of prostate cancer among men with a prostate-specific antigen level of ≤4.0 ng per milliliter
    • Thompson IM et al. (2004) Prevalence of prostate cancer among men with a prostate-specific antigen level of ≤4.0 ng per milliliter. N Engl J Med 350: 2239-2246
    • (2004) N. Engl. J. Med. , vol.350 , pp. 2239-2246
    • Thompson, I.M.1
  • 2
    • 17844402699 scopus 로고    scopus 로고
    • 20-year outcomes following conservative management of clinically localized prostate cancer
    • Albertsen PC et al. (2005) 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 293: 2095-2101
    • (2005) JAMA , vol.293 , pp. 2095-2101
    • Albertsen, P.C.1
  • 3
    • 0034125690 scopus 로고    scopus 로고
    • Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy
    • Epstein JI (2000) Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy. Am J Surg Pathol 24: 477-478
    • (2000) Am. J. Surg. Pathol. , vol.24 , pp. 477-478
    • Epstein, J.I.1
  • 4
    • 0038275923 scopus 로고    scopus 로고
    • Lead times and over-detection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer
    • Draisma G et al. (2003) Lead times and over-detection due to prostate-specific antigen screening: Estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 95: 868-878
    • (2003) J. Natl. Cancer Inst. , vol.95 , pp. 868-878
    • Draisma, G.1
  • 5
    • 4544254807 scopus 로고    scopus 로고
    • The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years?
    • Stamey TA et al. (2004) The prostate specific antigen era in the United States is over for prostate cancer: What happened in the last 20 years? J Urol 172: 1297-1301
    • (2004) J. Urol. , vol.172 , pp. 1297-1301
    • Stamey, T.A.1
  • 6
    • 0027468277 scopus 로고
    • Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy
    • Black WC and Welch HG (1993) Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 328: 1237-1243
    • (1993) N. Engl. J. Med. , vol.328 , pp. 1237-1243
    • Black, W.C.1    Welch, H.G.2
  • 7
    • 21044453581 scopus 로고    scopus 로고
    • Radical prostatectomy versus watchful waiting in early prostate cancer
    • Bill-Axelson A et al. (2005) Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352: 1977-1984
    • (2005) N. Engl. J. Med. , vol.352 , pp. 1977-1984
    • Bill-Axelson, A.1
  • 8
    • 0037404941 scopus 로고    scopus 로고
    • Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable
    • Hugossan J et al. (2003) Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable. J Urol 169: 1720-1723
    • (2003) J. Urol. , vol.169 , pp. 1720-1723
    • Hugossan, J.1
  • 9
    • 3042727071 scopus 로고    scopus 로고
    • Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
    • D'Amico AV et al. (2004) Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med 351: 125-135
    • (2004) N. Engl. J. Med. , vol.351 , pp. 125-135
    • D'Amico, A.V.1
  • 10
    • 0038653270 scopus 로고    scopus 로고
    • Variation of serum prostate-specific antigen levels: An evaluation of year-to-year fluctuations
    • Eastham JA et al. (2004) Variation of serum prostate-specific antigen levels: An evaluation of year-to-year fluctuations. JAMA 289: 2695-2700
    • (2004) JAMA , vol.289 , pp. 2695-2700
    • Eastham, J.A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.